BIOXCEL THERAPEUTICS INC.

In News

BTAI News | BIOXCEL THERAPEUTICS INC (NASDAQ:BTAI) - ChartMill

ChartMill - May 28, 2026

BioXcel Therapeutics Presents New Data from SERENITY - GlobeNewswire

GlobeNewswire - May 28, 2026

BioXcel Therapeutics, Inc. (BTAI) Expected to Beat Earnings Estimates: Should You Buy? - Yahoo Finance

Yahoo Finance - May 04, 2026

At-home bipolar and schizophrenia agitation drug cuts symptoms in Phase 3 - Stock Titan

Stock Titan - May 28, 2026

BioXcel Therapeutics Company Profile & Introduction - Moomoo

Moomoo - May 27, 2026

BTAI Financials: Income Statement, Balance Sheet & Cash Flow | Bioxcel Therapeutics Inc - Stock Titan

Stock Titan - May 15, 2026

BioXcel Therapeutics Announces Virtual Event to Discuss Commercial Launch Plan Based on Market Opportunity Assessment for IGALMI® in the At-Home Setting - Yahoo Finance

Yahoo Finance - Apr 17, 2026

How The BioXcel Therapeutics (BTAI) Story Is Shifting With BXCL501 Promise And Dilution Risks - Yahoo Finance

Yahoo Finance - Apr 13, 2026

[144] BioXcel Therapeutics, Inc. SEC Filing - Stock Titan

Stock Titan - May 20, 2026

BioXcel Therapeutics, Inc. (BTAI) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance

Yahoo Finance - May 15, 2026

BioXcel Therapeutics (BTAI) CEO exercises 18,000 RSUs, updates share holdings - Stock Titan

Stock Titan - May 07, 2026

How The BioXcel Therapeutics (BTAI) Story Is Shifting With Dilution Risks And Funding Needs - Yahoo Finance

Yahoo Finance - Mar 12, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment